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INT ROD UCT ION
The life-long blood supply is maintained by a pool of self-re-
newing, multipotent hematopoietic stem cells (HSCs), which 
are found in a quiescent state for most of their life (Orkin and 
Zon, 2008). In acute stress situations such as infection, che-
motherapy, and transplantation, proinflammatory cytokines 
such as IFN-α act as an emergency signal to recruit quies-
cent HSCs into an active cell cycle to replenish the com-
promised blood supply (Essers et al., 2009; Baldridge et al., 
2010). However, the underlying molecular mechanisms for 
this are poorly understood.
HSC quiescence is tightly regulated by paracrine and 
autocrine signals and direct interactions within the BM niche 
(Scadden, 2014). Cell surface receptors such as c-Kit, N-cad-
herin, or integrins mediate direct adhesion of HSCs to niche 
cells or their surrounding extracellular matrix (ECM; Ellis 
and Tanentzapf, 2010). Additionally, cytokines produced by 
niche cells such as TGF-β, stem cell factor, and CXCL12 
induce HSC quiescence and BM retention (Heissig et al., 
2002; Katayama et al., 2006; Itkin and Lapidot, 2011). The 
CXCL12–CXCR4 axis for instance is central in regulating 
HSC migration and homing to the BM niche and, in con-
trast, promoting HSC quiescence by inducing the expres-
sion of cell cycle inhibitors (Sugiyama et al., 2006; Nie et al., 
2008; Tzeng et al., 2011).
The BM ECM surrounding HSCs is composed of pro-
teoglycans, collagens, and noncollagenous proteins and can 
affect adhesion, migration, and proliferation of HSCs (Klein, 
1995; Ellis and Tanentzapf, 2010). Matrilins (Matns) comprise 
a family of oligomeric ECM adaptor proteins that connect 
these different ECM components, forming a supramolecular 
structure (Deák et al., 1999; Klatt et al., 2001). Matn1 and 3 
are mainly expressed in skeletal tissue, whereas Matn2 and 4 
show a broad expression pattern (Klatt et al., 2011). Matn1, 
2, and 3 have been shown to directly interact with integrins 
and activate several intracellular signaling pathways; however, 
the molecular mechanism of this signaling remains unre-
solved (Mann et al., 2007).
Here, we show that Matn4 is highly expressed in qui-
escent HSCs, and expression decreases during proliferative 
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stress, permitting the activation and expansion of HSCs. In-
triguingly, HSCs lacking Matn4 respond more effectively to 
stress and show a robust competitive transplantation advan-
tage, mediated by down-regulation of CXCR4 expression in 
Matn4-deficient HSCs in stress situations. In summary, our 
data suggest that high expression of Matn4 in HSCs confers a 
resistance to stress stimuli. In situations of acute stress such as 
infection or transplantation however, this protection is rapidly 
lost to allow HSCs to efficiently replenish the blood system.
RES ULTS AND DIS CUS SION
Matn4 is highly expressed in HSCs but dispensable for 
steady-state hematopoiesis
The ECM surrounding HSCs in the BM is poorly described. 
Gene expression analysis revealed that the ECM protein 
Matn4 is highly expressed in long-term HSCs (LT-HSCs) 
and severely down-regulated upon differentiation to short-
term HSCs and multipotent progenitor cells (Fig.  1  A). 
Matn1, Matn2, and Matn3 were only low expressed in stem 
and progenitor cells with no enrichment in HSCs (Fig. 1 A). 
To examine the role of Matn4 in normal hematopoiesis, mice 
lacking Matn4 (Matn4−/−) were generated. Previous studies 
using single or double KO models of Matns revealed func-
tional redundancy in this protein family (Aszódi et al., 1999; 
Mátés et al., 2004; Nicolae et al., 2007). Therefore, quadru-
ple KO mice lacking all four family members (Matn1–4−/−) 
were established from single mutant lines. Matn4−/− and 
Matn1–4−/− mice were viable, fertile, had a normal life span, 
and showed no apparent gross abnormalities. Whereas both 
Matn4−/− and Matn-1–4−/− mice presented with decreased 
Lin−Sca-1+cKit+ (LSK) numbers, their LT-HSC numbers 
were comparable with WT C57BL/6 mice (Fig. 1, B and C). 
Both KO models generated normal amounts of myeloid and 
lymphoid lineages with only minor differences in T cells and 
granulocytes (Fig. 1 D). Cell cycle analysis revealed compa-
rable numbers of quiescent HSCs (Fig. 1, E and F). In addi-
tion, in Matn4−/−, mice the lack of Matn4 is not compensated 
by increased expression of the other Matns (Fig. 1 G). Thus, 
under homeostasis, Matn4 is not required for the mainte-
nance of normal hematopoiesis and HSC quiescence.
Proliferative stress induces the down-
regulation of Matn4 in HSCs
Matn4 expression is highest in the most quiescent HSCs and 
anticorrelates with increasing proliferative activity from HSCs 
to progenitors. To test whether Matn4 transcript levels were 
also down-regulated when HSCs are forced to proliferate, 
different stress conditions were tested. Interestingly, gene 
expression profiling revealed Matn4 as the most down-
regulated gene in HSCs isolated from IFN-α–treated mice 
(Fig. 2 A), which could be confirmed on the protein level 
in HSCs isolated from mice treated with polyinosinic : 
polycytidylic acid (pI:C), inducing a strong IFN-α response 
(Fig. 2, B and C). In contrast, Matn4 down-regulation was 
abolished in HSCs isolated from Ifnar−/− and Stat1−/− mice, 
demonstrating that Matn4 expression levels in HSCs are 
controlled by Ifnar–Stat1 signaling (Fig.  2  D). In addition, 
treatment of mice with LPS, transplantation, irradiation, or in 
vitro culture of HSCs also led to a significant decline in Matn4 
levels in HSCs (Fig. 2 E). Collectively, these data indicate that 
stress-induced proliferation of HSCs is accompanied by a 
strong down-regulation of Matn4 in HSCs.
Loss of Matn4 leads to an increased HSC 
proliferation in response to stress
To test whether there is a functional link between the 
down-regulation of Matn4 and the activation of HSCs by 
IFN-α, HSC proliferation and blood recovery of WT and 
Matn1–4−/− mice were measured. pI:C treatment resulted 
in increased cell cycle entry of Matn1–4−/− HSCs compared 
with WT HSCs (Fig. 3 A), accompanied by a higher white 
blood cell (WBC) and platelet count during recovery (Fig. 3, 
B and C). To evaluate whether Matn1–4−/− showed improved 
recovery in other stress situations, mice were treated with the 
chemotherapeutic 5-fluorouracil (5-FU). As observed after 
pI:C treatment, Matn1–4−/− HSCs proliferated more in re-
sponse to 5-FU (Fig. 3 D) and showed more rapid recovery 
of WBCs and platelets (Fig. 3, E and F). Similar phenotypes 
were observed in Matn4−/− mice (not depicted). Despite their 
enhanced proliferative response, Matn1–4−/− HSCs returned 
to quiescence at the same time as WT HSCs after pI:C and 
5-FU treatment (Fig. 3, A–D). This was further supported by 
serial 5-FU treatments, where HSCs were repeatedly stressed 
just after recovery leading to their exhaustion and pancyto-
penia. There was no difference in the survival curves of WT 
and Matn1–4−/− mice upon serial 5-FU treatment, further 
supporting our hypothesis that Matn1–4−/− HSCs return to 
quiescence efficiently and to the same extent as WT HSCs, 
even after serial rounds of stress (Fig. 3 G).
Matn4 limits the expansion of HSCs and progenitors
Strikingly, both LSK as well as LT-HSC numbers were dra-
matically increased on day 9 after 5-FU treatment (Fig. 3, H 
and I; and Fig. S1). To show that this massive expansion is not 
caused by contamination of the HSC gate, we performed a 
CFU assay with equal numbers of sorted Matn1–4−/− and WT 
LSKs. Remarkably, Matn1–4−/− LSKs showed a higher colo-
ny-forming potential than WT LSKs, suggesting an increase 
in functional HSCs and progenitors (Fig. 3 J). In agreement 
with this, untreated Matn1–4−/− LSK cells also showed higher 
CFUs than WT cells with larger and more colonies, which 
was even more pronounced in secondary CFUs (Fig. 3 K). 
The increased colony size could be rescued by the addition 
of recombinant Matn4 to the CFU medium (Fig. 3 L). Addi-
tionally, WT colony size was significantly reduced upon addi-
tion of recombinant Matn4, suggesting that Matn4 generally 
exerts growth inhibitory effects on HSCs. Collectively, these 
data show that in the absence of Matn4, HSCs proliferate 
and expand more efficiently in response to stress, resulting in 
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Figure 1. Matn4 is highly expressed in HSCs but dispensable for 
steady-state hematopoiesis. (A) Matn2, 3, and 4 mRNA expression in 
LT-HSCs (Lin−Sca-1+c-Kit+CD150+CD48−CD34−), short term HSCs (ST-
HSCs; Lin−Sca-1+c-Kit+CD150+CD48−CD34+), and multipotent progenitors 
(MPPs; Lin−Sca-1+c-Kit+CD150+CD48+) of WT mice. (B) Representative LSK 
FACS plots showing percentage of LSK in WT, Matn4−/−, and Matn1–4−/− 
mice. (C) Absolute numbers of LSK and LSK CD150+CD48− of WT, Matn4−/−, 
and Matn1–4−/− mice determined by FACS and normalized to the total BM 
cell counts per femur. (D) Frequency of B cells (B220+), megakaryocytes 
(CD41+), granulocytes (CD11b+Gr-1+), T cells (CD4+CD8+), and erythrocytes 
(Terr119+) in BM of WT, Matn4−/−, and Matn1–4−/− mice determined by 
FACS. (E and F) Representative FACS plots (E) and quantification (F) of cell 
cycle distribution (Ki67/Hoechst) of WT, Matn4−/−, and Matn1–4−/− HSCs 
(LSK CD150+CD48−). (G) Matn1, 2, and 3 mRNA expression levels of HSCs 
(LSK CD150+CD48−) isolated from WT and Matn4−/− mice isolated 4 wk 
after transplantation, derived from microarray analysis. n = 3 mice/group. 
Unpaired Student’s t test analysis was performed on three independent 
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To further characterize this, single Matn4−/− HSCs were 
kept in liquid cultured for 7 d, and cell numbers and type 
of colonies were quantified. Matn4−/− HSCs produced larger 
colonies with a higher percentage of undifferentiated and 
mixed colonies (Fig. 3, M–P). Of note, a few days later, undif-
ferentiated colonies started to generate mixed colonies (not 
depicted), suggesting that Matn4−/− HSCs initially self-renew 
more before differentiating into larger colonies. The increase in 
undifferentiated colonies could be rescued by adding recombi-
nant Matn4 to the culture medium, supporting the hypothesis 
that Matn4 limits the expansion of HSCs (Fig. 3, O and P).
Matn4−/− HSCs show increased competitive repopulation 
capacity in BM transplantations
After transplantation into a lethally irradiated recipient, donor 
cells are confronted with an excess of inflammatory cytokines 
generated within the irradiated BM niche (Xun et al., 1994). 
To reestablish the hematopoietic system, a massive expan-
sion of donor HSCs and progenitors is required. To examine 
whether loss of Matn4 could enhance this expansion of HSCs 
upon transplantation, competitive BM repopulation assays 
were performed by mixing equal amounts of Matn4−/− or 
Matn1–4−/− BM cells with WT CD45.1 competitor BM cells 
(50:50%; Fig.4 A). Only 4 wk after transplantation, Matn4−/− 
and Matn1–4−/− cells comprised >80% of the blood gran-
ulocyte chimerism (Fig.  4  A). This competitive advantage 
was sustained over time, and Matn4−/− and Matn1–4−/− BM 
cells outcompeted WT CD45.1 cells across all differentiated 
lineages, up to HSCs (Fig.  4  B). In secondary competitive 
transplantations, Matn1–4−/− cells again rapidly showed im-
proved reconstitution (>80%; Fig. 4 C). Limiting dilution as-
says confirmed that the improved reconstitution capacity was 
not because of an increased number of functional HSCs but 
rather a proliferative advantage of Matn4−/− cells (Fig. 4 D).
Increased proliferative stress often leads to premature 
exhaustion of HSCs (Sato et al., 2009; Walter et al., 2015). 
Figure 2. Proliferative stress is associated with Matn4 down-regulation in HSCs. (A) Scatterplot of changes in mRNA expression levels of HSCs 
(LKCD150+CD48−) isolated from triplicate PBS- or IFN-α–treated WT mice (5 × 106 U/kg for 16 h), derived from microarray analysis. Matn4 is marked in red. 
(B) Representative immunofluorescence images of LT-HSCs (LSK CD150+CD48−CD34−) from WT mice treated with PBS or pI:C (5 mg/kg for 16 h), stained for 
Matn4 (red) and DAPI (blue). Bars, 5 µm. (C) Immunofluorescence images of LT-HSCs (LSK CD150+CD48−CD34−) from WT and Matn4−/− mice treated with PBS 
or pI:C (5 mg/kg for 16 h), stained for Matn4 (red) and DAPI (blue). n = 3. Bar, 20 µm. Representative images are from three independent experiments. (D) 
Fold change of Matn4 mRNA expression validated by qRT-PCR of sorted HSCs (LKCD150+CD48−) from PBS- or pI:C (5 mg/kg for 16 h)-treated WT, Stat1−/−, 
and Ifnar−/− mice. (E) Matn4 mRNA levels determined by qRT-PCR of WT HSCs (LSK CD150+CD48−) isolated 24 h after transplant, irradiation (2 × 500 Rad), 
or in vitro culture and LKCD150+CD48− HSCs after LPS (0.25 mg/kg for 24 h) treatment. (A, B, D, and E) n = 3 mice/group. (D and E) Unpaired Student’s t test 
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Figure 3. Loss of Matn4 leads to increased HSC proliferation and expansion in response to stress. (A–C) BrdU incorporation (14 h) of HSCs (LKCD150+CD48−; 
A), WBC counts (B), and platelet (Plt) counts from WT and Matn1–4−/− mice treated with PBS (0 d) or pI:C (5 mg/kg at 1, 2, 3, or 4 d). (D) Ki67/Hoechst staining of WT 
and Matn1–4−/− mice was determined 0, 5, 7, or 9 d after PBS or 150 mg/kg 5-FU treatment. (E and F) WBC counts (E) and platelet counts (F) of WT and Matn1–4−/− 
mice, determined 0, 7, 10, 14, 17, and 24 d after 150 mg/kg 5-FU treatment. (G) Survival curve of WT and Matn1–4−/− mice treated with 150 mg/kg 5-FU every 10 d. 
Injection time points are indicated by arrows. n = 6 mice/group of two independent experiments. (H) Absolute number (Abs.#) of LSKs per leg 0, 5, 7, and 9 d after 
150 mg/kg 5-FU treatment in WT and Matn1–4−/− mice. (I) Absolute numbers of WT and Matn1–4−/− LT-HSCs (LSK CD150+CD48−CD34−) per two femurs 9 d after 150 
mg/kg 5-FU treatment. (J) On day 9 after 5-FU treatment, 2,000 sorted WT and Matn1–4−/− LSKs were seeded in CFU assay. The number of colonies was quantified on 
day 7. (K) WT and Matn1–4−/− LSKs were seeded in CFU assay. The number of colonies was quantified on day 7 (1°CFU), reseeded for 2°CFU, and quantified again on 
day 7. (L) Fold increase in WT and Matn1–4−/− cell count of the 1°CFU with or without 100 ng/ml recombinant Matn4 at day 7. Rel., relative. (M–P) Individual WT or 
Matn4−/− HSCs (LSK CD150+CD48−) were sorted into culture medium with or without 100 ng/ml recombinant Matn4. Colony size and types were determined on day 7 
using microscopy imaging. Mk, megakaryocytes; Undiff, Undifferentiated. (M) Representative images of each colony type. Bars, 50 µm. (N) Number of cells per colony. 
(O) Percentage of colony types generated. (P) Number of undifferentiated colonies generated. (A–F and H–P) n = 3 mice/group. (A-P) Unless otherwise indicated, 
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Because KO HSCs proliferate more upon stress, we evaluated 
their long-term reconstitution capacity. Serial transplantation 
of 100% Matn4−/− or WT littermate BM showed a similar 
multilineage engraftment (Fig. 4 E) as well as the gradual de-
crease in reconstitution capacity (Fig. 4 F). Thus, the transient 
increase in proliferation upon stress observed in Matn-defi-
cient HSCs does not lead to premature exhaustion.
Down-regulation of CXCR4 expression increases 
proliferation and expansion of Matn4−/− HSCs upon stress
To gain insight into the molecular mechanism through 
which deletion of Matn4 affects HSC function under stress, 
transcriptional profiling of WT (CD45.1/2) and Matn4−/− 
HSCs was performed 4 wk after competitive transplantation 
(Fig. 5 A). The overall expression profile of WT and Matn4−/− 
HSCs showed a high correlation. Among the few differentially 
expressed genes was CXCR4, whereas other known Matn 
target genes such as collagen X and BMP2 remained un-
changed (Fig. 5, A and B). Furthermore, gene set enrichment 
analysis revealed transcripts involved in the MAPK signaling 
pathway and GTPase regulatory activity to be decreased in 
Matn4−/− HSCs (Fig. 5 C), pathways described downstream 
of CXCR4 (Busillo and Benovic, 2007). It is important to 
note that CXCR4 levels were equal under homeostasis and 
only reduced by 50% in transplanted Matn4−/− HSCs com-
pared with WT HSCs (Fig.  5 D). The homing capacity of 
Matn-deficient HSCs was not impaired, indicating that the 
CXCR4 down-regulation occurred after HSCs homed to 
the BM (Fig.  5, E and F). Furthermore, no increased mo-
bilization of HSCs could be detected in Matn1–4−/− mice 
in the baseline and upon stress (Fig.  5, G and H), suggest-
ing that Matn1–4−/− HSCs are effectively retained within the 
BM. CXCR4 and its ligand CXCL12 are not only crucial 
players in HSC homing and migration, but also have been 
shown to induce HSC cell cycle arrest in homeostasis and 
upon 5-FU treatment (Sugiyama et al., 2006; Nie et al., 2008; 
Figure 4. Matn4-deficient HSCs show improved long-term repopulation capacity. (A) Blood granulocyte (Gr1+CD11b+) chimerism of WT CD45.1/
Matn4−/− or WT CD45.1/Matn1–4−/− 50:50 chimeras, determined 0, 4, 10, and 16 wk after transplant. (B) BM chimerism of myeloid (CD11b+Gr-1+), B (B220+), 
and T cells (CD4+CD8+), HSCs (LSK CD150+CD48−), and whole BM of WT CD45.1/Matn1–4−/− 50:50 chimeras 16 wk after transplant. B, B cells; My, myeloid; T, 
T cells. (C) Blood granulocyte (Gr1+CD11b+) chimerism of secondary WT CD45.1/Matn1–4−/− 50:50 chimeras, determined 0, 4, 8, and 20 wk after transplant. 
(A–C) n = 6 mice/group. Unpaired Student’s t test analysis was performed on three independent experiments. ***, P < 0.001. Data are mean ± SD. (D) 3, 10, or 
30 sorted WT CD45.1/2 and Matn-4−/− LT-HSCs (LSK CD150+CD48−) were transplanted into lethally irradiated recipients, and engraftment was checked at 8 
and 12 wk. The number of HSCs was determined using the ELDA software. Two independent experiments and 3–6 mice/group are shown. (E) Serial transplan-
tations of 100% BM of four individual WT littermate or Matn4−/− mice, retransplanted every ≥16 wk into new lethally irradiated recipients. Blood chimerism 
was analyzed 12–14 wk after transplant. (F) Percent engraftment of WT littermate or Matn4−/− BM cells harvested from quaternary chimeras 16 wk after 
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McDermott et al., 2015). Indeed, inhibition of CXCR4 sig-
naling in WT (CD45.1/2) mice by AMD3100 treatment 
(Broxmeyer et al., 2005) led to increased proliferation of WT 
HSCs in response to 5-FU and pI:C stress, mimicking the 
phenotype of Matn4−/− mice (Fig. 5 I). Furthermore, when 
WT CD45.1/2/Matn4−/− 50:50% chimeras were treated 
with AMD3100, leading to the reduction of CXCR4 sig-
naling in WT CD45.1/2 HSCs, the proliferative advantage 
of Matn4−/− initially mediated by differences in CXCR4 ex-
pression was rescued (Fig.  5  J). Blood chimerism stayed at 
50% 4 wk after transplant and remained significantly lower 
than in the untreated chimeras, even after discontinuation of 
the AMD3100 treatment (Fig. 5  J). To further confirm the 
role of CXCR4, Matn4−/− LSK cells overexpressing CXCR4 
were competitively transplanted, and Matn4−/− chimerism 
remained at ∼50% up to 12 wk after transplant (Fig. 5 K). 
When CXCR4 was overexpressed in both WT (CD45.1/2) 
and Matn4−/− cells, we again observed a growth advantage of 
the Matn4−/− HSCs, indicating that the difference in endog-
enous CXCR4 levels is still sufficient to provide a compet-
itive advantage. However, we cannot exclude that additional 
factors are involved in generating a proliferative advantage in 
Matn-deficient HSCs. Overall, our data show that CXCR4 
signaling is an important factor in limiting the proliferation 
of HSCs in response to different stress stimuli of HSCs in 
general and establishing the competitive growth advantage of 
HSCs lacking Matn4 (Fig. 5 L).
In summary, we have uncovered a novel link between 
ECM component Matn4 and CXCR4 signaling, regu-
lating HSC proliferation and expansion in response to in-
flammatory stress, chemotherapy, and transplantation. Under 
homeostasis, high expression of Matn4 in HSCs confers a re-
sistance to stress stimuli. In situations of acute stress, Matn4 is 
down-regulated to release this protection to allow HSCs to 
efficiently replenish the blood system. Interestingly, in vitro 
recombinant Matn4 can act as a cytokine with growth in-
hibitory effects. However, in mixed chimeras, Matn4 pro-
duced by WT BM cannot rescue Matn4−/− HSC expansion, 
suggesting that Matn4 acts locally on HSCs through an au-
tocrine or even intracellular mechanism. Because reduced 
CXCR4 levels in Matn4−/− HSCs led to improved stress re-
covery and reconstitution upon transplantations, it will be of 
great interest to investigate whether the CXCR4 antagonist 
AMD3100 could be used to improve the recovery of patients 
from hematopoietic stress such as myelosuppressive chemo-
therapy and transplantation.
MAT ERI ALS AND MET HODS
Animals
Mice were maintained in individually ventilated cages in 
the DKFZ animal facility. Female 8–12-wk-old mice were 
used throughout the study. As controls, C57BL/6 (WT) or 
B6.SJL-Ptprca Pepcb/BoyJ (WT CD45.1) mice purchased 
from Envigo or Charles River, respectively, were used as indi-
cated. Control WT CD45.1/2 mice were obtained by crossing 
WT CD45.2 and WT CD45.1 mice. To generate Matn4−/− 
mice, a neomycin-thymidine kinase–containing selection cas-
sette floxed with loxP sites was introduced into the second 
intron and a single loxP site into the third intron of the mouse 
Matn4 gene. The targeting construct was electroporated into 
R1 embryonic stem (ES) cells and subjected to G418 selec-
tion. One homologous recombinant ES cell clone identified 
by Southern blotting was transiently transfected with Cre 
recombinase followed by selection against the thymidine ki-
nase gene with Fialuridine. ES cells carrying the null allele, 
which lacks exon 1 with the translation initiation codon as 
well as the selection cassette and only contains one loxP site 
in the second intron, were used to establish the Matn4−/− line. 
Matn4−/− mice were backcrossed more than eight times on a 
C57BL/6 background. Quadruple KO mice deficient for all 
Matn family members (Matn1–4−/−) were generated by inter-
crossing individual Matn4-, Matn3 (Ko et al., 2004)-, Matn2 
(Mátés et al., 2004)-, and Matn1 (Aszódi et al., 1999)-mu-
tant lines and backcrossed to a >90% C57BL/6 background. 
Ifnar−/− (Müller et al., 1994) and Stat1−/− (Durbin et al., 
1996) have been described previously. All animal protocols 
were approved by the Animal Care and Use Committees of 
the German Regierungspräsidium Karlsruhe für Tierschutz 
und Arzneimittelüberwachung.
In vivo treatments
Mice were injected i.p. with PBS; 5 mg/kg pI:C (Invivo-
Gen), 5 × 106 U/kg recombinant mouse IFN-α (Miltenyi 
Biotec), 0.25 mg/kg LPS (Escherichia coli 0111:B4; Sigma- 
Aldrich), and 150 mg/kg 5-FU; or s.c. with 5 mg/kg 
AMD3100 (Sigma-Aldrich). Chimeras were treated with 
AMD3100 starting 2 d after transplant to allow homing and 
then treated three times per week.
Isolation of BM cells and peripheral blood (PB)
Mice were sacrificed, and tibiae, femurs, sternum, coxae, and 
vertebral columns were crushed in RPMI-1640 medium 
(Sigma-Aldrich) supplemented with 2% FCS. For cell sort-
ing, lineage depletion was performed by incubating BM cells 
with rat monoclonal antibodies targeting CD4 (GK1.5), 
CD8a (53.6.7), CD11b (M1/70), B220 (RA3-6B2), Gr-1 
(RB6.8C5), and Ter119 (Ter119). Subsequently, cells were 
washed, and lin+ cells were removed using magnetic beads 
(Dynabeads; Invitrogen). For analysis of PB, four to five drops 
of blood were collected from the vena facialis into an ED-
TA-coated tube. Blood cells were analyzed using a hema-
tology system (Hemavet 950; Drew Scientific). For FACS 
analysis, erythrocytes were lysed with 1 ml ammonium-chlo-
ride-potassium lysing buffer.
Flow cytometry and cell sorting
BM cells were incubated with antibodies for 30 min on 
ice. BM cells were stained for HSCs and progenitors using 
antibodies CD4 (GK1.5), CD8 (53-6.7), CD11b (M1/70), 
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Figure 5. Proliferative advantage of Matn-4−/− HSCs is mediated by down-regulation of CXCR4. (A) Scatterplot showing changes in mean mRNA 
expression levels (microarray) of three WT CD45.1/2 and three Matn4−/− HSCs (LSK CD150+CD48+) isolated from WT CD45.1/2/ Matn4−/− 50:50 chimeras 
4 wk after transplant. CXCR4 is marked in red. (B) Collagen X (Col X) and BPM2 mRNA expression levels of sorted HSCs (LSK CD150+CD48−) from WT 
CD45.1/2/Matn4−/− 50:50 chimeras isolated 4 wk after transplant, derived from microarray analysis. Unpaired Student’s t test analysis was performed on 
three biological replicates. Data are mean ± SD. (C) Gene set enrichment analysis of activation of MAPK activity and GTPase regulatory activity using WT 
and Matn4−/− microarray gene expression data. Positively (red) and negatively (blue) regulated genes are shown (P < 0.05). FDR, false discovery rate; NES, 
normalized enrichment score. (D) Fold change of CXCR4 mRNA expression validated by qRT-PCR of sorted HSCs (LSK CD150+CD48−) from WT CD45.1/2/
Matn4−/− 50:50 chimeras (after transplant) or untransplanted WT CD45.1/2 and Matn4−/− mice (homeostatic), determined by qRT-PCR. (E) BM of WT 
CD45.1/2 and Matn1–4−/− was transplanted 50:50 i.v. or intrafemurally (i.f.). Blood granulocyte (Gr1+CD11b+) chimerism was checked 4 wk after transplant. 
(F) WT CD45.1/2 and Matn1–4−/− BM was transplanted 50:50 i.v. The absolute number (Abs. No) of LSKs per leg was determined by FACS 16 h after 
transplant. (G) Quantification of mobilized LSKs in the blood of untreated WT and Matn1–4−/− mice. (H) Quantification of mobilized LSKs in the spleen of 
untreated, pI :C -treated, or LPS-treated WT and Matn1–4−/− mice. (I) Ki67/Hoechst staining of WT HSCs (LSCD150+CD48−CD34−) after 150 mg/kg 5-FU (9 d) 
or 5 mg/kg pI:C treatment (2 d) and/or 5 mg/kg AMD3100 (every second day) treatment. (J) WT CD45.1/2/Matn4−/− 50:50 chimeras were treated with 5 mg/
kg AMD3100 for 8 wk (three times per week). Blood granulocyte (Gr1+CD11b+) chimerism was determined 0, 4, 8, 11, and 14 wk after transplant. n = 6 mice/
group. (K) 50:50 chimeras were generated using WT CD45.1/2 (black) or Matn4−/− (red) LSKs overexpressing CXCR4 or a Venus control. Blood granulocyte 
(Gr1+CD11b+) chimerism was determined 12 wk after transplant. (L) Schematic overview: under homeostatic conditions, WT and Matn4−/− HSCs express 
equal levels of CXCR4. Under stress conditions, Matn4−/− HSCs have reduced CXCR4 expression, resulting in a decreased inhibition of their cell cycle during 
acute stress. (A, B, D–I, and K) n = 3 mice/group. (D–J) Unpaired Student’s t test analysis was performed on three independent experiments. *, P < 0.05; **, 
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CD16/32 (93), CD41 (MW Reg 30), and CD105 (MJ7/18); 
and cKit (2B8), Sca-1 (D7), CD150 (TC15-12F12.1), 
CD48 (HM48-1), and CD34 (RAM34; eBioscience). When 
comparing untreated to pI :C /LPS -treated HSCs, Sca-1 was 
excluded from the gating because of its strong up-regulation. 
After 5-FU treatment, c-Kit was excluded from the HSC 
gating scheme, as its expression on HSCs is lost during 5-FU 
recovery. Cells were analyzed using an LSR II or LSR Fortessa 
flow cytometer (BD). Data were analyzed using FlowJo 
software (Tree Star). For FACS sorting, FAC SAria I, II, and 
III cell sorters were used (BD).
Cell cycle analysis
BM cells were stained with surface markers as described 
under the Flow cytometry and cell sorting section, fixed 
using Cytox/Cytoperm buffer (BD), and stained with Ki67 
antibody overnight at 4°C. Hoechst 33342 stain (Molecular 
Probes) was added at 25 µg/ml before FACS analysis. For 
the BrdU incorporation assay, mice were injected i.p. with 
18 mg/kg BrdU (Sigma-Aldrich) 14 h before harvesting the 
BM. For BrdU staining, the BD BrdU Flow kit was used.
BM transplantations
3 × 106 cells were diluted in 100–200  µl PBS and i.v. in-
jected into lethally irradiated (2 × 500 rad) mice. For mixed 
BM chimeras, 1.5 × 106 BM cells of each genotype were 
mixed before i.v. injection. For 2° chimeras, WT and KO BM 
of 1° 50:50 chimeras at week 16 were mixed 1:1 and trans-
planted into lethally irradiated recipients. Mice were kept on 
antibiotics (Cotrim) for 3 wk after transplant. Blood chime-
rism was monitored monthly.
Limiting dilution assay
3, 10, and 30 sorted WT CD45.1/2 or Matn4−/− LT-HSCs 
were transplanted i.v. together with 2 × 105 supportive BM 
cells into lethally irradiated WT CD45.1 recipients. PB was 
analyzed for myeloid and lymphoid reconstitution at 8 and 
12 wk, and HSC engraftment in BM was analyzed at 14 wk. 
Mice for which engraftment was <1% were considered non-
engrafted and were not taken into account for calculation of 
stem cell frequencies. Calculation of stem cell frequencies and 
statistics was performed using ELDA software.
Homing assays
3 × 106 BM cells were injected either i.v. or intrafemurally into 
lethally irradiated recipients, and blood chimerism was mon-
itored monthly. Alternatively, 50 × 106 BM cells per mouse 
were transplanted i.v., femurs were harvested after 16 h, and 
the number of LSKs in the BM was analyzed by FACS.
Generation of CXCR4 retrovirus
A retroviral overexpression system for CXCR4 was generated 
using the SF91 retroviral vector (Milsom et al., 2009). Viral 
supernatants were generated from Phoenix cells (ATCC). 
Cells were transfected with either SF-CXCR4 or SF-Venus 
using calcium phosphate transfection (Invitrogen). Retroviral 
supernatant was harvested 48  h after transfection, concen-
trated by ultracentrifugation, and stored at −80°C until use.
In vitro culture
After FACS sorting, cells were cultured in Stem-Pro34 me-
dium (Invitrogen) supplemented with 1% l-glutamine, 1% 
penicillin/streptomycin, 26% N-2 Supplement (Invitrogen), 
50 ng/ml Flt3, 50 ng/ml mouse thrombopoietin, and 50 ng/
ml mouse stem cell factor (R&D Systems). Cells were cul-
tured at 37°C and 5% CO2.
Transduction of mouse LSK cells
LSK cells were cultured in Stem-pro34 medium for 48 h and 
transferred to nontissue culture–coated plates (BD) precoated 
with fibronectin CH296 fragment (Takara Bio Inc.) at 4 µg/
cm2. LSK cells were seeded with concentrated retroviral su-
pernatant at a multiplicity of infection of 4. 36 h later, cells 
were harvested, and live Venus+ cells were sorted.
Immunofluorescence
Sorted HSCs were added onto Polysine slides and incu-
bated at room temperature for 15 min. Cells were fixed with 
Cytox/Cytoperm buffer (BD) for 10 min, blocked with 15% 
goat serum (Dako), and incubated with a rabbit polyclonal 
antibody against Matn4 (ab106379; Abcam) overnight at 4°C. 
Subsequently, slides were incubated for 1 h at 4°C with anti–
rabbit IgG-F(AB)2-DyLight649 (Jackson ImmunoResearch 
Laboratories, Inc.) and mounted with ProLong Gold mount-
ing medium containing DAPI (Invitrogen). Slides were an-
alyzed on a cell observer (ZEI SS) and documented with an 
AxioCam HR camera (ZEI SS).
Colony forming assay
500 LSK cells were plated in 1 ml of Methocult 3434 (STE 
MCE LL Technologies) supplemented with PBS or 100 ng/ml 
recombinant Matn4 (R&D Systems). Colonies consisting of 
>40 cells were counted using an inverted microscope after 7 d.
Microarray
4 wk after transplant, HSCs were sorted, and RNA was iso-
lated using an RNA isolation kit (Arcturus PicoPure; Applied 
Biosystems). 2.5 ng RNA was used for hybridization onto 
the Mouse Sentrix-6 Bead-Chip array (Illumina). Microarray 
data were deposited in NCBI’s Gene Expression Omnibus 
under accession no. GSE72814.
Quantitative real-time PCR (qRT-PCR)
Cells were FACS sorted into 50–100 µl of extraction buf-
fer (Arcturus PicoPure kit), and RNA was isolated with the 
PicoPure RNA isolation kit (Arcturus). RNA was reverse 
transcribed with the SuperScript VILO cDNA synthesis kit 
(Invitrogen). For qRT-PCR, the ViiA 7 Real-Time PCR sys-
tem (Applied Biosystems) was used with 384-well plates. Sdha 
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tive gene expression was calculated by the comparative ΔΔ 
cycle threshold method. The primers used in the real-time 
PCR were: Matn4 forward, 5′-TTA GCA CCA TGA CGC 
ACCT-3′; reverse, 5′-GGA CTC CGA AGC TCT GTCC-3′; 
CXCR4 forward, 5′-GAC TGG CAT AGT CGG CAA TG-3′; 
reverse, 5′-AGA AGG GGA GTG TGA TGA CAAA-3′; SDHA 
forward, 5′-AAG TTG AGA TTT GCC GAT GG-3′; and re-
verse, 5′-TGG TTC TGC ATC GAC TTC TG-3′.
Statistical analysis
For statistical analysis and graphical representation of data, 
Prism 6.0 (GraphPad Software) was used. Statistical analysis 
was performed using two-tailed unpaired Student’s t tests. All 
data are expressed as mean ± SEM unless otherwise indicated. 
Statistical significance is indicated by *, P < 0.05; **, P < 
0.01; and ***, P < 0.001.
Online supplemental material
Fig. S1 shows the gating scheme used to gate on LSK 
cells after 0, 5, 9, and 12 d of 5-FU treatment. Online 
supplemental material is available at http ://www .jem .org /
cgi /content /full /jem .20151713 /DC1.
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